featured
Patient-Reported Adverse Effects Reduced When Switching From Oral to Subcutaneous Methotrexate
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Patient reported adverse effects when switching from oral to subcutaneous administration of methotrexate - a prospective, multi-centre, paired cohort study
J Am Acad Dermatol 2021 Dec 30;[EPub Ahead of Print], D Jef, K Cb, B M, B A, J GbeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.